Clinical Trials
2 trialsNCT00561756 2015-11-17
Vaccine Therapy in Treating Patients With Recurrent B-Cell Lymphoma
Memorial Sloan Kettering Cancer Center
Phase 1 Completed
NCT00562068 2013-08-26
Alemtuzumab and Combination Chemotherapy in Treating Patients With Stage I, Stage II, Stage III, or Stage IV Peripheral T-Cell Lymphoma
National Cancer Institute (NCI)
Phase 1 Unknown